Recently, the Financial Dagblad awarded Delft Imaging the prestigious Oryx Prize. The Oryx Prize, the grand award of the FD Gazellen Awards, the recipient as ‘the greatest company,’ chosen to inspire the jury and other enterprises. The jury commended us for our international perspective and social commitment and recognized our contributions to advancing global health equity through innovative diagnostic solutions.
Tackling global health challenges
We are dedicated to improving healthcare access in resource-constrained environments. Our portable X-ray systems and CAD AI solutions are operational in 85 countries, enabling efficient and accurate TB detection and ultrasound screening. To date, these systems have facilitated screening over 32 million individuals in low- and middle-income countries (LMICs).
Driving innovation beyond TB
Our work extends beyond TB care, reflecting our commitment to innovation. BabyChecker, our artificial intelligence solution, analyses obstetric ultrasound scans to identify risks in pregnancy. This handheld tool allows frontline health workers to conduct scans in less than two minutes, improving maternal health outcomes.
Acknowledgment of excellence
The Oryx Prize jury recognized us for our innovative solutions, commitment to addressing global health challenges, and reinvestment in diagnostic technologies. This accolade underscores our role in building sustainable healthcare systems worldwide.
We are grateful to our team for their dedication to this mission. Together, we remain committed to delivering impactful solutions that save lives and strengthen healthcare systems globally.
